As the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonists continues to reshape the landscape of metabolic health in the United…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key Regulator for Preventing Muscle Loss During GLP-1 Weight Loss Treatments and Aging
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine, offering unprecedented efficacy…
Read More
Salk Institute Identifies Med14 Protein as Key Regulator for GLP-1 Agonists’ Long-Term Pancreatic Health Benefits
Salk Institute researchers have pinpointed a crucial protein, Med14, that acts as a molecular bridge connecting GLP-1 agonist drugs to…
Read More
Salk Institute Researchers Identify BCL6 Protein as Key to Preventing Muscle Loss During GLP-1 Weight Management and Aging
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally transformed the landscape of metabolic medicine, offering unprecedented efficacy in…
Read More
